Security key
31447P100
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC)
CUSIP: 31447P100
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Shares, no par value
- Total 13F shares
- 16,313,327
- Total 13F value
- $175,058,668
- Share change
- +84,244
- SEC-reported price per share
- $10.75
- Number of holders
- 104
- Value change
- +$14,051,827
- Number of buys
- 68
- Number of sells
- 25
- Shares outstanding
- 34,988,259
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
104
Top holders
10
FENC full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
FENNEC PHARMACEUTICALS INC. SEC filings
FENNEC PHARMACEUTICALS INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31447P100
Recent filing periods:
Ownership snapshot
Top reported holders of FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Rosalind Advisors, Inc.
Disclosed value leader
Rosalind Advisors, Inc.
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 9.6%
13D/G row: Rosalind Advisors, Inc.
Showing 1-6 of 15 holder rows.
Quick read
Rosalind Advisors, Inc. leads the comparable SEC ownership view at 9.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Rosalind Advisors, Inc.'s linked filing trail.
Comparable ownership
Top 5
Rosalind Advisors, Inc.
9.6%
Sonic Fund II, L.P.
8.2%
Orin Hirschman
5.7%
Solas Capital Management, LLC
5.4%
DG Capital Management, LLC
4.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. |
13D/G
13F
Company
|
9.6%
|
$35,704,330
3,321,333 shares
|
+$3,007,850 | 30 Jun 2026 |
| Sonic Fund II, L.P. |
13D/G
Kam Lawrence
|
8.2%
|
$21,503,685
2,799,959 shares
|
$0 | 31 Dec 2025 |
| Orin Hirschman |
13D/G
|
5.7%
|
$12,186,826
1,981,501 shares
|
$0 | 31 Mar 2026 |
| Solas Capital Management, LLC |
13D/G
13F
Company
|
5.4%
|
$20,310,684
1,889,366 shares
|
-$6,372,944 | 30 Jun 2026 |
| DG Capital Management, LLC |
13D/G
|
4.1%
|
$6,342,597
1,114,692 shares
|
$0 | 31 Dec 2024 |
| Southpoint Capital Advisors LP |
3/4/5
13F
10%+ Owner · Company
|
7.8%
|
$20,585,557
2,744,741 shares
|
-$10,341,902 | 24 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
104
Shares
16,313,327
Rows available
104
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q4 2025 Across Filers
Q4 2025 holders
96
Q2 2026 holders
104
Holder diff
8
| Investor | Q4 2025 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend